CCB lecture Flashcards

1
Q

Ca key role in physiological processes

A

contractility of skeletal, cardiac & smooth muscles

- release of NT from vesicles by exocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

at resting state, intracellular Ca is

A

low (<0.1micrometers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

at resting state, extracellular Ca is

A

10,000 fold higher (~1mM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

[Ca] achieved by

A
  • active efflux pumps

- active reuptake into SR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

mechanisms mediating increase in intracellular Ca

A
  • voltage sensitive Ca channels
  • agonist-mediated Ca release
  • receptor-operated Ca channels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

voltage-sensitive Ca channels

A
  • open in response to depolarization of the cell membrane (L-type, T-type, N-type)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

L-type

A

long-lasting large channels (cardiac & smooth muscle cell, SA & AV nodal cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T-type

A

transient tiny channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

N-type

A

neuronal tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

agonist mediated Ca release

A

results from activation of 2nd messengers (IP3) by agonist to release intracellular Ca from storage sites (SR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

receptor-operated Ca channels

A

receptor forms a channel & the channel opens when the receptor is occupied by a ligand (NMDA receptor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what initiates contraction of vascular smooth muscle cells?

A

entry of Ca into SMC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what initiate contraction of cardiac myocytes?

A

entry of Ca into myocardial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CCBs inhibit

A

L-type Ca channels-> decreased influx of Ca->

  • < SMC contraction->vasodilation (blood flow)
    • ionotropic effec-> < O2 demand
  • < pacemaker rate of SA node & conduction velocity of AV node-> - chronotropic effect-> < O2 demand
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DHP access what channel?

A

CLOSED channel & stabilize it

- mainly act on arterial muscle cells-> VASODILATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

non-DHP binds to the

A

OPEN channel & inactivate it & slow down the recovery

-more pronounced effects in the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

“cardio-selective” drugs

A

non-DHP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

“vascular-selective” drugs

A

DHP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

therapeutic uses for CCBs

A

HTN
Angina pectoris
superventricular arrhythmia
migraine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

main adverse effects of verapamil & diltiazem

A

(non-DHP: Cardio-selective)

  • cardiodepression
  • hypotension, AV node blackade, peripheral edema, elevation of liver enzymes’- HA, flushing, dizziness, constipation
  • caution: inhibition oF CYP3a4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

main adverse effects of amlodipine

A

(DHP: not cardio-selective)

  • edema, dizziness, flushing, palpitation, gingival hyperplasia
  • cardio, CNS, GI side effection
  • long term use may > breast cancer risk
  • caution combining w/ CYP3A4 inhibitors-> hypotenion, kidney failure
22
Q

alpha 1 adrenergic receptor blocker MOA

A

blockage of alpha 1 adrenoreceptors in arteries & veins

- probably blockade of central alpha 1 receptors

23
Q

main ADE of alpha 1 blockers

A

first-dose effect: postural/orthostatic hypotension (alpha 1 receptors in veins)

24
Q

activation of alpha 1 receptors leads to

A

constriction

25
alpha 1 blocker drugs
doxazosin terazosin prazosin
26
central alpha 2 adrenoreceptor agonist MOA
- activation of central alpha 2 receptors(CV control centers)-> suppression of sympathetic outflow from the brain - possible stimulation of presynaptic alpha2-> dec. NE release - clonidine: possible interaction with central imidazoline receptors
27
central alpha 2 agonist drugs
clonidine guanfacine guanebenz methyldopa
28
clonidine bioavailability
100% | - 50% is eliminated in urine unchanged- caution in renal failure
29
clonidine main therapeutic effects
- < BP (central effect) - < HR (< sympathetic drive & > vagal tone) - < intraocular pressure (used in glaucoma)
30
main adverse effect of clonidine
- sedation & dry mouth - sexual dysfunction (due to hyperprolactinemia) - bradycardia - withdrawal rxn w/ abrupt DC
31
guanfacine (tenex) elimination
50% eliminated unchanged in urine
32
guanebenz (wytensin) metabolism
100% metabolized in liver
33
methyldopa is similar in structure to
tyrosine
34
tyrosine is a precursor for
epi & NE
35
what central alpha 2 agonist is a prodrug?
methyldopa
36
methyldopa can also be beneficial in
preeclampsia
37
peak effect of methyldopa
delayed 6-8 hours | duration ~24hrs
38
ADE of methyldopa
similar to clonidine + hepatotoxicity & hemolytic anemia
39
methyldopa MOA
- stored in secretory vesicles of adrenergic neurons, substituting NE - released into synaptic cleft instead of NE - effects similar to clonidine
40
methyldopa needs to be _____ to act
transported into CNS
41
what kind of drug is reserpine?
sympatholytic
42
what is the first drug that was found to interdere with the function of SNS in humans? (start of antihypertensive therapy)
reserpine
43
resperine MOA
- IRREVERSIBLY binds to the vesicular transporter | - BP lowering effects due to both central & peripheral actions
44
reserpine ADE
- > retention of Na & water - sedation & inability to concentrate - depression & suicidal thoughts - caution: should be DC at first sign of depression
45
what kind of drug is hydralazine (apresoline)?
direct vasodilation
46
hydralazine MOA
direct vasodilation
47
main therapeutics effects of hydralazine
- effective decrease in peripheral resistance (powerful stimulation of SNS->usually combined w/ other drugs) - minimal effect on veins-> no postural hypotension
48
Main ADE of hydralazine
- drug induced lupus - > retension of Na & H2O - HA, flushing, hypotension, tachycardia, angina pectoria - caution: aggravation of myocardial ischemia
49
what kind of drug is minocidil (Loniten)?
direct vasodilator
50
MOA of minoxidil
- prodrug that needs to be converted to minoxidil sulfate - activates ATP-dependent K+ channels in smooth muscles->efflux of K+ from cells-> hyperpolarization-> relaxation of smooth muscle
51
main therapeutic effects of minoxidil
dilation of arterioles similar to hydralazine-> decreased PR (powerful SNS stimulation- usually combined w/ other drugs)
52
main ADE of minoxidil
- > retention of Na and water - tachycardia, angina pectoris, myocardial ischemia - hypertrichosis (hair growth)